The DOI matches its Crossref record.
The Influence of Ritanserin, a Serotonin Antagonist, in Anxiety Disorders: A Double-blind Placebo-controlled Study versus Lorazepam
Abstract
A double-blind study was performed in 83 patients with generalized anxiety disorder comparing daily doses of 5 and 10 mg ritanserin (a selective antagonist of serotonine S 2 receptors) versus placebo and 4 mg lorazepam as reference drug. Patients treated with 10 mg ritanserin or 4 mg lorazepam improved significantly better (p<0.05) after two weeks than those treated with placebo. On the other hand a daily dose of 5 mg ritanserin appeared to be not superior to placebo. Patients treated with 4 mg lorazepam complained significantly more about sedation and dizziness than patients treated with 10 mg ritanserin (p<0.05). Zusammenfassung Eine Doppelblindstudie wurde an 83 Patienten mit Angstund Spannungszuständen durchgeführt, wobei Tagesgaben von 5 und 10 mg Ritanserin (eines selektiven Serotonin-S 2 - Rezeptorentagonisten) gegen Plazebo und 4 mg Lorazepam als Bezugspräparat verglichen wurden. Die mit 10 mg Ritanserin oder 4 mg Lorazepam behandelten Patienten zeigten eine signifikant größere Verbesserung (p<0.05) nach 2 Wochen als die mit Plazebo behandelten Patienten. Andererseits erschien eine Tagesdosis von 5 mg Ritanserin der Plazebogabe nicht überlegen. Patienten, die mit 4 mg Lorazepam behandelt worden waren, klagten signifikant häufiger über Sedierung und Schwindelgefühl als diejenigen Patienten, welche mit 10 mg Ritanserin behandelt wurden (p < 0.05).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Griebel, G. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)98597-j · Cited by 488
Charney, D. S., Woods, S. W., Goodman, W. K., & Heninger, G. R. (1987) · Psychopharmacology · doi:10.1007/bf00215473 · Cited by 462
Dulawa, S. C., & Hen, R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.017 · Cited by 430
Gould, R. A., Otto, M. W., Pollack, M. H., & Yap, L. (1997) · Behavior Therapy · doi:10.1016/s0005-7894(97)80048-2 · Cited by 352
Serotonin and brain development
Sodhi, M. S. K., & Sanders-Bush, E. (2004) · International Review of Neurobiology · doi:10.1016/s0074-7742(04)59006-2 · Cited by 340
The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist
Jones, B. J., Costall, B., Domeney, A. M., Kelly, M. E., Naylor, R. J., Oakley, N. R., & Tyers, M. B. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11489.x · Cited by 327
Role of the amygdala and periaqueductal gray in anxiety and panic.
Graeff, F. G., Silveira, M. C. L., Nogueira, R. L., Audi, E. A., & Oliveira, R. M. W. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90097-a · Cited by 301
The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic
Blanchard, D. C., Griebel, G., & Blanchard, R. J. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01276-7 · Cited by 295
Serotonin, the periaqueductal gray and panic
Graeff, F. G. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.12.004 · Cited by 285
van Praag, H. (1987) · Journal of Affective Disorders · doi:10.1016/0165-0327(87)90067-x · Cited by 265
Serotonin and anxiety revisited
Kahn, R. S., van Praag, H. M., Wetzler, S., Asnis, G. M., & Barr, G. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90091-1 · Cited by 258
5HT drugs in animal models of anxiety
Handley, S. L., & McBlane, J. W. (1993) · Psychopharmacology · doi:10.1007/bf02247358 · Cited by 253
Burghardt, N. S., Bush, D. E. A., McEwen, B. S., & LeDoux, J. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.023 · Cited by 179
Deakin, J. F. W., Pennell, I., Upadhyaya, A. J., & Lofthouse, R. (1990) · Psychopharmacology · doi:10.1007/bf02253723 · Cited by 132
Gomez, A. F., Barthel, A. L., & Hofmann, S. G. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1472767 · Cited by 125
Benzodiazepines and anxiety disorders: a review for the practicing physician
Kaplan, E. M., & DuPont, R. L. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x48401 · Cited by 55
Metadata
- Authors
- Ceulemans, D., Hoppenbrouwers, M.-L., Gelders, Y., & Reyntjens, A.
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 1985-09
- Volume
- 18
- Issue
- 05
- Pages
- 303-305
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2049807538
- Cited by
- 226
- References
- 0
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.